Kathryn D. Bungartz

Kathryn D. Bungartz

Auto-generated profile, based on publicly available information

Kathryn D. Bungartz

Deputy Editor, AJHG

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
KBKathryn D Bungartz
Kathryn D Bungartz
KLKristen Lalowski
Kristen Lalowski
SESheryl K Elkin
Sheryl K Elkin

1 January 2009 in The American Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
KBKathryn D. Bungartz
Kathryn D. Bungartz
RWRobin E. Williamson
Robin E. Williamson
Type I diabetes mellitus (T1DM) results from the body's inability to produce sufficient insulin and is typically diagnosed in children (juvenile diabetes). Diabetes results in high levels of blood sugar, which may lead to capillary damage. Retinopathy and kidney damage (nephropathy) are among the potential complications of T1DM. Although diabetic nephropathy (DN) is the primary cause of death in T1DM patients, only about 30% of T1DM patients develop this condition. There is evidence of a genetic component to the development of DN in T1DM; however, the complication does not follow simple Mendelian rules of inheritance. He and colleagues use a multistage association study of a region of chromosome 3q22 previously linked with DN in T1DM patients to identify genetic factors that might influence the occurrence of this condition. Finish, Icelandic, and British patients with T1DM are divided into two groups: those with no clinical sign of renal damage (1874 patients) and those with end-stage renal disease (ESRD), determined by persistent large amounts of albumine in the urine (macroalbuminuria) and retinopathy (1822 patients). Initial screening identifies 27 associated SNPs in one Finish cohort. Replication in the other populations finds significant association of the minor allele C of SNP rs1866813 with DN (odds ratio = 1.33). Although haplotype-block analysis reveals no stronger association, the intergenic region containing rs1866813 is evolutionarily conserved. These data suggest that rs1866813 might influence one or a number of neighboring genes expressed in the glomerulus of the kidney, including NCKI and TMEM22.

1 July 2011 in The American Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
KBKathryn D. Bungartz
Kathryn D. Bungartz
RWRobin E. Williamson
Robin E. Williamson
Two types of acromelic dysplasia, geleophysic dysplasia (GD) and acromicric dysplasia (AD), are clinically defined disorders each of which is characterized by extreme short stature with bone and joint abnormalities and distinct facial features. In this issue, Le Goff and colleagues use exome sequencing and subsequent Sanger sequencing to identify mutations in FBN1 in individuals with GD and in those with AD. The involvement of FBN1disruption in these growth disorders is particularly interesting because mutations in the gene are known to cause Marfan syndrome for which tall stature is a defining phenotype. How can disruption of the same gene lead to such different clinical presentations? The authors analyze their mutations in an effort to start to address that question. Of particular note is that each of the 16 mutations identified in individuals with GD or AD is located in the region that encodes the TGF-β binding protein like 5 (TB5) domain. In patient cells, these mutations disrupt microfibril formation and organization and enhance TGF-β signaling. TGF-β activation is also seen in Marfan syndrome, so additional regulatory factors must be involved in the differential mutation effects. One player may be ADAMTSL2. The gene encoding ADAMTSL2 has been shown previously to be mutated in individuals with GD, and here, Le Goff et al. demonstrate that FBN1 and ADAMTSL2 interact directly with each other. Additional analyses will contribute to our growing interest!

1 January 2011 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KBKathryn D. Bungartz
Kathryn D. Bungartz
RWRobin E. Williamson
Robin E. Williamson

10 July 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
KBKathryn D. Bungartz
Kathryn D. Bungartz
RWRobin E. Williamson
Robin E. Williamson

11 November 2011 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KBKathryn D. Bungartz
Kathryn D. Bungartz